Cheaper Sleep Medications?

Guess what? The time has actually come for the patent of one of the most widely used sleep medications in the world -- Ambien -- to come to an end. According to a recent article in The Sleep Report:

This year alone, 10 brand-name medications with revenue exceeding $8.1 billion are expected to lose patent exclusivity, including the widely prescribed sleep medication Ambien (zolpidem tartrate).

• Ambien's US sales exceeded $2 billion last year.


• Medications to treat sleep disorders are one of the fastest growing categories of drug spending, rising 31.5% in 2005 alone according to Medco Health Solutions Inc, a pharmacy benefit manager.


• While seniors use the most hypnotics, younger adults showed the greatest increase in use of these drugs.


• According to Medco's analysis, the number of adults aged 20 to 44 years using sleeping medications increased by 128% between 2000 and 2005.


• According to pharmacy market analyst IMS Health, a one percent increase in generic utilization nationwide yields almost $4 billion in savings.

So what does this mean for those of you who are taking these valuable medications?

First, you should know that the makers of Ambien have done a great job of reducing the price of their newest medication, Ambien CR, so that it will match or come very close to the price of generic.

Next, I hope to see insurance companies recognizing that the use of these medications can in fact LOWER our healthcare premiums, but I doubt it.

Related Topics:

• To Sleep, Perchance to Sleep Soundly
• WebMD Video: Sleeping Pills

Technorati Tags: The Sleep Doctor, sleeping pills, sleep medications, ambien, health and wellness